Wingert, J., Meinhardt, E., Sasipong, N., Pott, M., Lederer, C., Torre, C. d. l., . . . Schlegel, P. (2024). Cardiomyocyte-specific RXFP1 overexpression protects against pressure overload-induced cardiac dysfunction independently of relaxin. Biochemical pharmacology, 225, . https://doi.org/10.1016/j.bcp.2024.116305
Chicago Style (17th ed.) CitationWingert, Julia, et al. "Cardiomyocyte-specific RXFP1 Overexpression Protects Against Pressure Overload-induced Cardiac Dysfunction Independently of Relaxin." Biochemical Pharmacology 225 (2024). https://doi.org/10.1016/j.bcp.2024.116305.
MLA (9th ed.) CitationWingert, Julia, et al. "Cardiomyocyte-specific RXFP1 Overexpression Protects Against Pressure Overload-induced Cardiac Dysfunction Independently of Relaxin." Biochemical Pharmacology, vol. 225, 2024, https://doi.org/10.1016/j.bcp.2024.116305.